Tessera Therapeutics Stock
Tessera Therapeutics is a biotechnology company that focuses on a new category of genetic medicines.
Sign up today and learn more about Tessera Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Tessera Therapeutics Stock
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
Co-Founder & Chief Scientific Officer
President and CFO
Chief Data Officer
Co-Founder, Chief Executive Officer & Board member
Geoffrey von Maltzahn